Effect of Different Doses Vitamin D and Calcium Supplementation on Blood Glucose and Insulin Sensitivity in Middle-Aged and Elderly Patients with Impaired Glucose Tolerance
Min Jiang,Juan Cao,Yu Xie,Wen Zheng,Wei Zhang,Hui Wang,Chun Wang
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2016.12.009
2016-01-01
Abstract:Objective To explore the effect of different doses of vitamin D (VitD) and calcium supplementation on blood glucose and insulin sensitivity in middle?aged and elderly patients with impaired glucose tolerance (IGT). Methods A total of 150 individuals with IGT [aged (57 ± 4) years] were chosen during physical examination from January 2013 to May 2015, of which 80 cases were male and 70 were female. They were randomly divided into three groups:regular dose group (group A, n=49, VitD 125 U/d+calcium 600 mg/d), double dose group (group B, n=51, VitD 250 U/d + calcium 1 200 mg/d), and control group (group C, n=50, no medication). Oral glucose tolerance test (OGTT) was performed before and after VitD and calcium supplementation. Blood biochemical parameters were measured. Homeostasis model assessment (HOMA) insulin resistance index (HOMA?IR) and HOMA isletβ?cell function index (HOMA?β) were calculated. Comparison of means was done by one?way analysis of variance (ANOVA). LSD?t test was used when P<0.05 as the limit for statistical significance.appropriate. Correlation analysis was performed using Pearson correlation analysis and multiple stepwise regression analysis. Results (1) Compared with group C, fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG) and insulin (2hINS), glycated hemoglobin A1c (HbA1c), HOMA?IR in group A and B declined significantly (P<0.05) after 6 and 12 months of VitD and calcium treatment, while the level of serum 25(OH)D and HOMA?βwere dramatically increased (all P<0.05). (2) After 6 and 12 months treatment, HbA1c, HOMA?IR significantly declined from baseline [HbA1c:(5.9 ± 0.5)%,(5.9 ± 0.6)%;HOMA?IR:(3.8 ± 0.9, 3.7 ± 0.7)] in group A [HbA1c:(5.7 ± 0.2)%,(5.6 ± 0.6)%;HOMA?IR:3.6±1.1, 3.4±1.5] and group B [HbA1c:(5.7±0.6)%,(5.5±0.4)%;HOMA?IR:2.8±1.5 vs 2.0±1.2] (all P<0.05). And the levels of FPG and 2hPG were also reduced. The differences were significantly (all P<0.05). (3) In addition, FINS, 2hINS, HbA1c and HOMA?IR in 12 months after treatment were declined in group B compared with group A, while the level of serum 25(OH)D in group B was increased [(40 ± 5)vs (32 ± 6)μg/L] ( all P<0.05).(4) Pearson correlation coefficient analysis showed that serum 25(OH)D in 12 months post?treatment was positively correlated with HOMA?β(r=0.210), serum calcium (r=0.444) (both P<0.05); while was negatively correlated with HbA1c (r=-0.241), FPG (r=-0.215) and HOMA?IR (r=-0.225) (P<0.05). Multiple regression analysis indicated that serum 25(OH)D in patients with IGT was markedly positively correlated with HbA1c (r=2.138) VitD doses (r=7.160 for regular?dose, 7.330 for double dose) and total cholesterol (r=2.319) (P<0.05). Conclusion Vitamin D and calcium supplementation can improve blood glucose and insulin sensitivity in middle?aged and elderly patients with IGT, in a dose and time dependent manner.